3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year Post author:Sam Post published:November 20, 2017 Post category:BioPharma Investors have had a decent year, but some have much to be grateful for this Thanksgiving. Source: BioSpace You Might Also Like Former GlaxoSmithKline CEO and R&D Boss Secure New Gigs at Biotech VC Firms September 18, 2017 ArQule To Present Clinical Data At The 2017 ASCO Annual Meeting May 17, 2017 71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite's CAR-T Therapy December 11, 2017
71% of ALL Patients Achieved Complete Tumor Remission on Gilead, Kite's CAR-T Therapy December 11, 2017